ANIP News and Press, ANI Pharmaceuticals Inc. From 04/04/19

Private equity shops Apollo Global Management and CVC Capital Partners are apparently bidding  for Perrigo's ( PRGO +2.6% ) generic pharmaceuticals unit according to informed sources who add that the business could fetch more than $2.5B. More news on: Perrigo Company plc, Akorn, In...

ANI Pharmaceuticals ( ANIP -1.2% ) has launched 18mg and 27mg Methylphenidate Hydrochloride Extended-Release Tablets, indicated as a treatment for Attention Deficit Hyperactivity Disorder ("ADHD"). More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

BAUDETTE, Minn. , March 27, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced the launch of 18mg and 27mg Methylphenidate Hydrochloride Extended-Release Tablets, indicated as a treatment for Attention Deficit Hyperactivity Disorder...

ANI Pharmaceuticals Inc (ANIP) Q4 2018 Earnings Conference Call February 27, 2019 10:30 AM ET Company Participants Arthur Przybyl - President and Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participants Elliot Wilbur - Raymond James Dewey...

ANI Pharmaceuticals ( ANIP ) Q4 results : Revenues: $57.1M (+20.7%). More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

ANI Pharmaceuticals (NASDAQ: ANIP ): Q4 Non-GAAP EPS of $1.32 beats by $0.08 ; GAAP EPS of $0.46 beats by $0.02 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BAUDETTE, Minn. , Feb. 27, 2019 /PRNewswire/ -- For the full year ended December 31, 2018 : Record net revenues of $201.6 million , an increase of 14% versus 2017 GAAP net income of $15.5 million and diluted GAAP earnings per share of $1.30 Adjusted non-GAAP EBITDA ...

AES , AMRN , AMT , ANIP , BBY , CHK , CLH , CPB , DF , DNR , DOC , DY , EYE , FTDR , GCP , GTE , HMLP , HPT , HZNP , IONS , LIVN , LOW , LXP , MDCO , MGPI , MIDD , NEWM , NOVT , OCN , ODP , PEG , PGTI , PNM , RDC , SBGI , SHOO , TAST , TJX , UTHR F...

ANI Pharmaceuticals (NASDAQ: ANIP ) is scheduled to announce Q4 earnings results on Wednesday, February 27th, before market open. The consensus EPS Estimate is $1.24 (+14.8% Y/Y) and the consensus Revenue Estimate is $53.48M (+13.1% Y/Y). Over the last 2 years, ANIP has beaten EPS est...

BAUDETTE, Minn. , Feb. 20, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and year-to-date 2018 financial results on Wednesday, February 27, 2019 , before the opening of the U.S. financial markets. The ea...